A price slash for Coach (COH) may have investors thinking twice before picking up the handbag maker stock. Credit Suisse (CS) lowered its price target for Coach to $30 per share from $39 due to future sales. The firm is keeping its Neutral rating for the stock. But a brighter outlook for a glaucoma drug maker, Aerie Pharmaceuticals (AERI). Canaccord initiated coverage of the drugmaker with a buy rating and a price target set at $40 per share. And Jefferies is raising its price target for Toyota Motors (TM) to $139.80 per share. The firm is also reiterating its BUY rating for the stock. TheStreet's Susannah Lee has the details in today's Analysts' Actions from Wall Street.

If you liked this article you might like

Watch This Retail CEO Quickly Explain How to Survive Hurricane Amazon

Michael Kors Stock Has Nearly 50% Upside Even With Amazon Crushing Everyone

Coach CEO Perfectly Explains What Must Be Done to Survive Retail Apocalypse

Coach Has More On Its Plate Than Just Fashion Week Craziness

Coach Flaunts Hot New Look for Fashion Week